Navigation path

Toradh an chuardaigh

Líon na gcáipéisí a fhreagraíonn do critéir chuardaigh sin: 40586
(Nasc chuig an bhfotha RSS)

Uimhir tagartha an doiciméidAn Ard-Stiúrthóireacht a bhfuil an cúram sin uirthiDáta foilsithe
C(2019)2432/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2431/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "Autologous CD34+ cells transduced with a lentiviral vector containing the human ADA gene" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2430/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "Autologous CD34+ cells transfected with lentiviral vector containing the human arylsulfatase A cDNA" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2429/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "Edaravone" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2428/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2427/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2426/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2425/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2424/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "Miglustat" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council
C(2019)2423/- SANTE (AS um Shláinte agus Sábháilteacht Bia) 25/03/2019
Cinneadh cur chun feidhme ón gCoimisiún
COMMISSION IMPLEMENTING DECISION concerning the transfer of the designation of "Recombinant human acid alpha-glucosidase" as an orphan medicinal product under Regulation (EC) No 141/2000 of the European Parliament and of the Council

Líon na gcáipéisí a fhreagraíonn do critéir chuardaigh sin: 40586
(Nasc chuig an bhfotha RSS)